Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,156 | 37,032 | -6,668 | -28,235 | -18,843 |
| Depreciation Amortization | 12,370 | 26,938 | 19,925 | 12,938 | 6,283 |
| Income taxes - deferred | -15,371 | 9,500 | -6,129 | -2,292 | -1,266 |
| Accounts receivable | 104,502 | -115,803 | -64,325 | -13,637 | 5,668 |
| Accounts payable and accrued liabilities | -2,003 | -528 | 643 | 1,637 | -2,496 |
| Other Working Capital | 70,526 | -132,381 | -88,713 | -58,833 | -20,713 |
| Other Operating Activity | -95,741 | 164,933 | 95,538 | 35,614 | 11,432 |
| Operating Cash Flow | $21,127 | $-10,309 | $-49,729 | $-52,808 | $-19,935 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,146 | -14,151 | -9,499 | -7,264 | -3,626 |
| Investing Cash Flow | $-3,146 | $-14,151 | $-9,499 | $-7,264 | $-3,626 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9,840 | -1,171 | -869 | -573 | -285 |
| Common Stock Issued | N/A | 157 | 155 | 25 | 25 |
| Other Financing Activity | -10,373 | -16,346 | -11,837 | -1,796 | -1,796 |
| Financing Cash Flow | $-20,213 | $-17,360 | $-12,551 | $-2,344 | $-2,056 |
| Beginning Cash Position | 94,331 | 136,151 | 136,151 | 136,151 | 136,151 |
| End Cash Position | 92,099 | 94,331 | 64,372 | 73,735 | 110,534 |
| Net Cash Flow | $-2,232 | $-41,820 | $-71,779 | $-62,416 | $-25,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,127 | -10,309 | -49,729 | -52,808 | -19,935 |
| Capital Expenditure | -3,146 | -14,151 | -9,499 | -7,264 | -3,626 |
| Free Cash Flow | 17,981 | -24,460 | -59,228 | -60,072 | -23,561 |